Severinsen Rune, Lau Jesper F, Bondensgaard Kent, Hansen Birgit S, Begtrup Mikael, Ankersen Michael
Medicinal Chemistry, Novo Nordisk A/S, Novo-Nordisk Park 2760, Maaloev, Denmark.
Bioorg Med Chem Lett. 2004 Jan 19;14(2):317-20. doi: 10.1016/j.bmcl.2003.11.012.
An efficient solid-phase protocol for the synthesis of substituted (5-biphenyltetrazolyl)-hydantoins and -thiohydantoins has been developed. Suzuki cross-coupling between resin-bound 2-(tetrazol-5-yl)-phenylborinane and 4-bromobenzaldehyde gave the corresponding tetrazolylbiphenyl aldehyde. Subsequent reductive amination using amino acid esters gave the pivotal resin bound amino acid esters which were transformed to hydantoins or thiohydantoins via two routes: (i) treatment with isocyanates or isothiocyanates or (ii) successive treatment with triphosgene and primary amines. Using molecular modeling, we were able to jump from L-692,429, a well known non-peptidyl growth hormone secretagogue (GHS), to biphenyltetrazolyl hydantoins, obtaining compounds with IC(50) values below 600 nM after two iterative cycles only.
已开发出一种用于合成取代的(5-联苯基四唑基)乙内酰脲和硫代乙内酰脲的高效固相方案。树脂结合的2-(四唑-5-基)-苯硼烷与4-溴苯甲醛之间的铃木交叉偶联反应得到相应的四唑基联苯醛。随后使用氨基酸酯进行还原胺化反应,得到关键的树脂结合氨基酸酯,其通过两条路线转化为乙内酰脲或硫代乙内酰脲:(i)用异氰酸酯或异硫氰酸酯处理,或(ii)依次用三光气和伯胺处理。通过分子建模,我们能够从著名的非肽类生长激素促分泌剂(GHS)L-692,429跳跃到联苯基四唑基乙内酰脲,仅经过两个迭代循环就获得了IC(50)值低于600 nM的化合物。